AMRI CEO to Present at the 32nd Annual J.P. Morgan Healthcare Conference
{window.open('https://sns.qzone.qq.com/cgi-bin/qzshare/cgi_qzshare_onekey?url='+encodeURIComponent(location.href)+'&title='+encodeURIComponent(document.title)+'&summary=&desc=&pics=https://static.prnasia.com/pro/pcom/includes/images/logo-prn-02_PRN.png','_blank','width=650,height=450');})()){kind=link}
ALBANY, New York, Jan. 9, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the 32nd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2014 at 7:30 a.m. PT.
A webcast of the presentation can be accessed at the Investor Relations' section of www.amriglobal.com, or at the following URL:
http://jpmorgan.metameetings.com/confbook/healthcare14/directlink?ticker=AMRI. The webcast will be archived for 90 days following the live presentation.
Source: AMRI
Related stocks: NASDAQ:AMRI
Featured Video
Related Keywords:
Health Care/Hospital Recent Releases
- ASRock Rack Launches New Servers Supporting the NVIDIA Blackwell Architecture at COMPUTEX 2024
- Innovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting
- Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
- CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
- Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer
- Read more